New Report Says Concept Medical Positioned to Disrupt Peripheral Market - Diagnostic and Interventional Cardiology

New Report Says Concept Medical Positioned to Disrupt Peripheral Market  Diagnostic and Interventional Cardiology

Analysis by GlobalData says company poised to take market share from major device manufacturers following FDA Breakthrough Therapy Designation.



Comments

Post a Comment

Popular posts from this blog

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease - Vascular Disease Management

Orchestra BioMed™ Announces FDA Breakthrough Device Designation for Virtue® Sirolimus-Eluting Balloon for Treatment of Below-the-Knee Peripheral Artery Disease    Vascular Disease Management First and only non-coated sirolimus-eluting angioplasty balloon system to receive Breakthrough Device designation for below-the-knee disease; Follows ...
Read more